Skip to main navigation Skip to search Skip to main content

Blocking of fimbria-mediated adherence of Haemophilus influenzae by sialyl gangliosides

  • L. van Alphen*
  • , L. Geelen-van den Broek
  • , L. Blaas
  • , M. van Ham
  • , J. Dankert
  • *Corresponding author for this work
  • University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The structure of the receptor for the fimbriae of Haemophilus influenzae on human oropharyngeal epithelial cells and erythrocytes was determined in inhibition experiments with various sugars, glycolipids, and glycoproteins. Of 30 monosaccharides and disaccharides at a concentration of 0.1 M and of 3 polysaccharides at a concentration of 1 mg/ml, none inhibited fimbria- specific adherence and hemagglutination. Inhibition was obtained with gangliosides GM1, GM2, GM3, and GD1a in nanomolar concentrations, whereas the asialo derivative of GM1, sialyl-lactose, and sialoglycoproteins were poor inhibitors. These findings indicate that sialyl-lactosylceramide (GM3) is the minimal structure for the fimbria-dependent binding of H. influenzae to its receptor on oropharyngeal epithelial cells and erythrocytes. As is the case with GM2, substitution of GM3 with N-acetylgalactosamine makes the molecule a 10-fold-better receptor analog.
Original languageEnglish
Pages (from-to)4473-4477
JournalInfection and immunity
Volume59
Issue number12
Publication statusPublished - 1991
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Blocking of fimbria-mediated adherence of Haemophilus influenzae by sialyl gangliosides'. Together they form a unique fingerprint.

Cite this